Trafalgar International (GCAN) Prepaid Assets (2019 - 2020)
Trafalgar International (GCAN) posted Prepaid Assets of $10000.0 for Q4 2020, down 60.0% on a QoQ basis from $25000.0 in Q2 2019.
Analysis
Trafalgar International (GCAN) Prepaid Assets (2019 - 2020) Analysis & Trends
Trafalgar International has reported Prepaid Assets for 2 years, with the latest figure at $10000.0 in Q4 2020.
- On a quarterly basis, Prepaid Assets changed N/A year-over-year to $10000.0 in Q4 2020; TTM through Dec 2020 was $10000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $10000.0, changed N/A from the prior year.
- Prepaid Assets was $10000.0 for Q4 2020 at Trafalgar International, down from $25000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $25000.0 in Q2 2019, with the low at $10000.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 651.77 Bn | 631.01 Bn | 17.26 Bn |
| 2 | AbbVie | 447.56 Bn | 440.99 Bn | 12.70 Bn |
| 3 | Merck | 364.58 Bn | 357.44 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.98 Bn | 261.29 Bn | 11.24 Bn |
| 5 | Pfizer | 158.03 Bn | 146.33 Bn | 10.94 Bn |
| 6 | Sanofi | 52.29 Bn | 44.91 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.18 Bn | 43.18 Bn | - |
| 8 | Incyte | 25.12 Bn | 20.58 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - |